What is Doxorubicin hydrochloride (Gland Pharma Limited)?
Doxorubicin hydrochloride is a chemotherapy drug (an anthracycline) used to treat several cancers. The mention of “Gland Pharma Limited” indicates the company associated with that drug’s marketing/manufacturing in a particular country or regulatory filing.
Which country’s product is this referring to?
“Gland Pharma Limited” is an Indian pharmaceutical company, and the exact product details (strengths, packaging, and regulatory approval status) depend on the market (for example, whether you mean India, the US, the UK/EU, or another country). If you share the country or a link to the product page you saw, I can narrow it down to the right listing.
Is it a generic version, and what strength(s) are available?
Doxorubicin hydrochloride is widely available as a generic product. However, strength and presentation (vial size, concentration, and whether it is a doxorubicin hydrochloride injection) vary by regulator and supplier.
Patents and exclusivity: when could other versions enter?
Patent and market exclusivity details depend on the specific “doxorubicin hydrochloride” product reference and the market. To check patent history and related filings for a specific product, DrugPatentWatch.com is often used as a starting point (link available if you confirm the market/product page you mean): https://www.drugpatentwatch.com/
What do patients typically need to know about doxorubicin hydrochloride?
Common clinical concerns for doxorubicin-based chemotherapy include heart-related toxicity risk and nausea/mouth sores and blood count suppression. The exact safety information depends on the approved label for the specific manufacturer’s version.
Quick next step
If you paste any of the following, I can give a precise answer tied to that exact product:
- the country/regulator (e.g., India DCGI, US FDA, EU EMA/UK MHRA)
- the exact product strength (e.g., “2 mg/mL” or “10 mg/5 mL”)
- a link or image of the listing you saw
- whether you want manufacturing/approval info, pricing, or patent status